Inventor · disambiguated record
Pascal André Stein
Also filed as: STEIN PASCAL A · STEIN PASCAL ANDRE · STEIN PASCAL ANDRÉ
11 granted patents·2 pending applications·266 citations·filing 2002–2018
91Inventor score
Files withMERCK PATENT GMBH6WEBSTER GORDON D2CANCER RESEARCH TECH LTD1EMD LEXIGEN RES CT CORP1EMD SERONO RES CT INC1
Top patents by PatentIndex Score
13 records- 0198US7186804B2IL-2 fusion proteins with modulated selectivityEMD LEXIGEN RES CT CORP·Filed 2002·Granted Mar 6, 2007·140 cites·23 claims
- 0297US7888071B2DNA encoding IL-2 fusion proteins with modulated selectivityMERCK PATENT GMBH·Filed 2008·Granted Feb 15, 2011·48 cites·26 claims
- 0395US7462350B2Cancer treatments including administering IL-2 fusion proteins with modulated selectivityEMD SERONO RES CT INC·Filed 2006·Granted Dec 9, 2008·34 cites·4 claims
- 0489US7872107B2Interleukin-12p40 variants with improved stabilityMERCK PATENT GMBH·Filed 2006·Granted Jan 18, 2011·15 cites·29 claims
- 0586US8691952B2Anti-CD19 antibodies with reduced immunogenicitySUPER MICHAEL·Filed 2006·Granted Apr 8, 2014·8 cites·32 claims
- 0683US8188248B2Nucleic acids encoding interleukin-12P40 variants with improved stabilityWEBSTER GORDON D·Filed 2010·Granted May 29, 2012·8 cites·32 claims
- 0782US9029330B2Methods of treating cancer using interleukin-12p40 variants having improved stabilityWEBSTER GORDON D·Filed 2012·Granted May 12, 2015·7 cites·26 claims
- 0881US8957195B2Anti-CD19 antibodies with reduced immunogenicityMERCK PATENT GMBH·Filed 2014·Granted Feb 17, 2015·3 cites·32 claims
- 0973US8907066B2Antibody fusion proteins with a modified FcRn binding siteLO KIN-MING·Filed 2010·Granted Dec 9, 2014·2 cites·9 claims
- 1072US10072092B2Methods of use of anti-CD19 antibodies with reduced immunogenicityMERCK PATENT GMBH·Filed 2015·Granted Sep 11, 2018·1 cites·17 claims
- 1169US11208496B2Anti-CD19 antibodies with reduced immunogenicityCANCER RESEARCH TECH LTD·Filed 2018·Granted Dec 28, 2021·0 cites·1 claims
- 1254US2015274797A1Antibody Fusion Proteins with a Modified FcRn Binding SiteMERCK PATENT GMBH·Filed 2014·Application pending·0 cites
- 1352US2007104689A1Compositions and methods for treating tumors presenting survivin antigensMERCK PATENT GMBH·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →